Human papillomavirus (HPV) is a common sexually transmitted infection that in some cases leads to cervical cancer. Indian women face a considerably high risk of death from cervical cancer. Clinical studies have demonstrated that HPV vaccines are a safe and effective way of preventing cervical cancer. Healthcare professionals play a critical role in the uptake of HPV vaccination in India. In this scoping review, the available evidence related to the knowledge, attitudes, and beliefs of medical professionals and students, surrounding HPV vaccination in India was reviewed and summarized. Overall, the knowledge about HPV vaccination was low among medical professionals and students in India, but higher knowledge was observed with higher years of medical education and among specialists such as gynecologists. Low awareness was commonly reported in several studies, especially among pharmacy and paramedical students indicating a need for targeted educational interventions. Willingness to get vaccinated was moderate and was higher among women. HPV vaccine administration rates were quite low, mostly among pediatricians. Most physicians expressed positive attitudes toward HPV vaccination, but pediatricians reported hesitancy to discuss with parents about their adolescent daughters’ reproductive lives, indicating the unmet needs regarding provider training and education. Findings from this scoping review highlight the necessity for more inclusive research encompassing a broader range of health professions and conducted across various regions of India to obtain a comprehensive understanding of the attitudes towards HPV vaccination and for programs and policy development in the future.
This study estimated the incremental burden of comorbid depression on healthcare resource utilization (HCRU) and costs, functional limitations, health-related quality of life (HRQoL), and missed workdays, among adults with irritable bowel syndrome (IBS). This cross-sectional study used 2016-2021 Medical Expenditure Panel Survey data to identify adults with IBS, with or without comorbid depression. The incremental effect of comorbid depression on HCRU was assessed using negative binomial models, while healthcare cost components were examined using generalized linear and two-part models. Functional limitations were assessed using logistic regression. Multivariable linear and negative binomial regression models were used to compare HRQoL (physical [PCS] and mental [MCS] component summary scores) and missed workdays, respectively, between groups. The sample included 1,422,146 (unweighted = 746) adults with IBS in the US, of whom 33.40% had depression. After adjusting for covariates, individuals with IBS and comorbid depression had significantly higher HCRU and costs across all categories than those without. Comorbid depression was significantly associated with greater odds of functional limitations. The mean MCS score was significantly lower among individuals with comorbid depression (mean difference: -14.80; 95% CI: -19.90 to -9.71), while no significant difference was observed in PCS. Individuals with comorbid depression reported 4.99 more missed workdays (95% CI: 4.64-5.36), compared to those without depression. Comorbid depression is associated with higher HCRU and costs, greater functional impairment, poorer mental HRQoL, and more missed workdays, among individuals with IBS. Targeted screening and better management of depression may improve outcomes in this population.